Table 4.
Characteristics | All patients (n=31), n (%) | Other (n=20), n (%) | EUS-HG (n=11), n (%) | P* |
---|---|---|---|---|
Duodenal revision | ||||
No | 21 (67.7) | 14 (70) | 7 (63.6) | 1 |
Yes | 10 (32.3) | 6 (30) | 4 (36.4) | |
Biliary revision | ||||
No | 24 (77.4) | 14 (70) | 10 (90.9) | 0.37 |
Yes | 7 (22.6) | 6 (30) | 1 (9.1) | |
Duodenal complication | ||||
No | 26 (83.9) | 16 (80) | 10 (90.9) | 0.63 |
Yes | 5 (16.1) | 4 (20) | 1 (9.1) | |
Biliary complication | ||||
No | 13 (41.9) | 6 (30) | 7 (63.6) | 0.13 |
Yes | 18 (58.1) | 14 (70) | 4 (36.4) | |
Clavien-Dindo classification | ||||
I | 5 (27.7) | 3 (21.4) | 2 (50) | 0.18 |
IIIb | 10 (55.6) | 9 (64.3) | 1 (25) | |
IVa | 1 (5.6) | 1 (25) | ||
V | 2 (11.1) | 2 (14.3) | ||
Significant complication (Clavien-Dindo classification) | ||||
No | 18 (58.1) | 9 (45) | 9 (81.8) | 0.07 |
Yes | 13 (41.9) | 11 (55) | 2 (18.2) | |
Death before 30 days | ||||
No | 25 (80.6) | 16 (80) | 9 (81.8) | 1 |
Yes | 6 (19.4) | 4 (20) | 2 (18.2) |
*Chi-square or Fisher’s exact or Wilcoxon’s test P values. HG: Hepaticogastrostomy